ARTEMISMEDArtemis Medicare Services Limited Forensic Risk Analysis

Hospital
Risk ClassStable
Market Cap₹3,643 Cr
Primary DriverGrowth Sustainability
Flagium AI Risk Score
Stable structural profile. Financial profile appears resilient.
5 / 100
+5 QoQ
Early Deterioration
Sentinel Insight

Financial profile remains stable for now. Weakness is detected in growth sustainability. No immediate concerns are visible. Risk is increasing at a faster pace.

0.0th %ile (Sector)Accel: +1 Qtrs
Updated2026-06-02
Market View
₹270.9▲1.23%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Growth Sustainability
+10.0 pts
Balance Sheet Stress
+8.0 pts
Stability Adjustment
-13.0 pts
Final Composite Risk5 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 0 → 5 over 12 quarters.

Expected Direction
⚠ Watch
Primary Deterioration Drivers
  • Inventory Stress
  • Working Capital Expansion
  • Capex Efficiency Stress
What to Watch Next Quarter
  • Inventory turnover
  • Working capital efficiency
  • Operating profit margins

Active Risk Objects (3)

CriticalHigh
Inventory Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ4 FY2026
Inventory growth (34.5%) significantly outpaced revenue growth (13.8%).

"Stock is piling up in the warehouse. Inventory turnover is slowing down dangerously."

Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 2 Years
More Detail
Impact Weight10/15
MomentumAccelerating
Last SignalQ4 FY2026
Working capital expansion detected: Receivable days increased by 3.7%.

"Early signs of working capital expansion. Receivable or inventory days are creeping up."

Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2025
Aggressive Capex (19.2%) amidst slow revenue growth (9.4%).

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)2.276.95✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+61.0+51.0✅ RESILIENT
Forensic Benchmark Context: Hospital (n=17 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹270.9(+1.23%)
1M Divergence+8.7%
1 Week-4.49%
1 Month+10.97%
6 Months+1.8%
1 Year-1.17%
2 Year+55.9%
3 Year+216.88%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The structural architecture is currently robust. Capital resilience buffers in growth sustainability remain well-maintained against forensic benchmarks. Systematic scans of core structural metrics confirm the absence of material structural stress. Strategic vigilance is advised as structural decay is accelerating.

ARTEMISMED • MARKET STRUCTURE

Stage 2 — Advancing

The company is in a growth phase. Institutional sentiment is highly positive, supported by strong fundamentals and sustained risk reduction.

Stage Transition Prob.90%
Trend QualityStrong
Phase Progression
Phase Progression Score82.5%
Readiness LabelHigh (Phase Transition Imminent)
Probability of Advancing90%
CoinTree Momentum
Composite Z-Score+0.1034σ
Improving momentum strength
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#816 of 2716
Top 30.04% in momentum strength
Timeframe Sparklines
1W-4.5%
1M+11.0%
6M+1.8%
Weinstein Indicators
150 DMA₹251.55
200 DMA₹247.82
150 DMA Slope+1.9100%Rising
Relative Strength+4.46%Leading
Relative Turnover (RTR)1.1905
ParticipationNeutral

PEER COMPARISON

Ranked comparison against sector peers

This company appears relatively stable compared to the Sector Mean (15).
ARTEMISMEDArtemis Medicare Services Limited
5 Risk
Sector %ile0th
Delta+5
Active Flags3
Accel+1
Growth Sustainability

Stable

APOLLOHOSPApollo Hospitals Enterprise Limited
5 Risk
Sector %ile0th
Delta+5
Active Flags2
Accel+1
Balance Sheet Stress

Stable

AGARWALEYEDr. Agarwal's Health Care Limited
19 Risk
Sector %ile63th
Delta-5
Active Flags7
Accel+0
Balance Sheet Stress

Stable

GPTHEALTHGPTHEALTH
30 Risk
Sector %ile81th
Delta-5
Active Flags22
Accel+0
Earnings Quality

Watch

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
10100th %ile
VS Sector Median (8.5)
Balance Sheet Stress
660th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
00th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Inventory Stress

2026

Working Capital Expansion

2025

Working Capital Expansion

2025

Capex Efficiency Stress

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY20261,111104132227
FY202597082146246
FY202488649109254
FY202374538127242